RecruitingNot ApplicableNCT06285357
The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.
A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection.
Sponsor
Lo.Li.Pharma s.r.l
Enrollment
100 participants
Start Date
Feb 19, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.
Eligibility
Sex: FEMALEMin Age: 25 YearsMax Age: 65 Years
Inclusion Criteria1
- HR-HPV DNA test positivity
Exclusion Criteria1
- No HSIL
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTEGCG + folic acid + B12
EGCG + folic acid + B12
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06285357
Related Trials
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
NCT074283301 location
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
NCT074534591 location
Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)
NCT072255301 location
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NCT072815994 locations
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT062913111 location